Shandong Weigao Group Medical Polymer Company Limited (1066) -
Financial and Strategic SWOT Analysis Review
Reference Code: GDME12707FSA Publication Date: AUG 2012
No.312 Shichang Road Phone +86 63 15622570 Revenue 3,180.58 (million CNY)
Weihai, SDG Fax +86 63 15620563 Net Profit 3,462.17 (million CNY)
264209 Website www.weigaogroup.com Employees 7,875
1066 [Growth
China Exchange Industry Medical Equipment
Enterprise Market]
Company Overview
Shandong Weigao Group Medical Polymer Company Limited (Weigao) is a medical devices company. It undertakes the
research, development, manufacture and sale of disposable medical consumables, orthopedic materials, and blood purification
products. The product portfolio of the company comprises over 110 infusion sets, needles, syringes, blood bags, heart eluting
stents, pre-filled syringes, blood sampling products, PVC Granules, orthopedic products, blood purification consumables and
blood purification equipments.
Key Executives SWOT Analysis
Name Title Shandong Weigao Group Medical Polymer Company
Zhang Hua Wei Director Limited, SWOT Analysis
Miao Yan Guo Director Strengths Weaknesses
Wang Zhi Fan Director Consistent Top-Line Growth Geographical Concentration in
Wu Chuan Ming Director China
Robust Sales and Marketing
Wang Yi Director Presence
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Opportunities Threats
Share Data
Shandong Weigao Group Medical Polymer Company Strategic Business Initiatives Stringent Government
Limited Regulations
Market Growth in Emerging
Share Price (CNY) as on 16-Aug- 8.76 Countries Competitive Landscape
2012
EPS (CNY) 0.78
Source: Annual Report, Company Website, Primary and Secondary Research,
Market Cap (million CNY) 32,399 GlobalData
Enterprise Value (million CNY) 30,642
Shares Outstanding (million) 4,476
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Financial Performance
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Shandong Weigao Group Medical Polymer Company Limited Reference Code: GDME12707FSA
(1066) - Financial and Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 3
List of Figures ................................................................................................................................................................................. 3
Section 1 - About the Company.......................................................................................................................................................... 4
Shandong Weigao Group Medical Polymer Company Limited - Key Facts ........................................................................................ 4
Shandong Weigao Group Medical Polymer Company Limited - Key Employees ............................................................................... 5
Shandong Weigao Group Medical Polymer Company Limited - Key Employee Biographies ............................................................. 6
Shandong Weigao Group Medical Polymer Company Limited - Major Products and Services .......................................................... 7
Shandong Weigao Group Medical Polymer Company Limited - History ............................................................................................ 8
Shandong Weigao Group Medical Polymer Company Limited - Company Statement ..................................................................... 10
Shandong Weigao Group Medical Polymer Company Limited - Locations And Subsidiaries........................................................... 11
Head Office ................................................................................................................................................................................... 11
Other Locations & Subsidiaries ..................................................................................................................................................... 11
Joint Venture................................................................................................................................................................................. 11
Section 2 – Company Analysis ......................................................................................................................................................... 12
Shandong Weigao Group Medical Polymer Company Limited - Business Description .................................................................... 12
Shandong Weigao Group Medical Polymer Company Limited - SWOT Analysis............................................................................. 13
SWOT Analysis - Overview........................................................................................................................................................... 13
Shandong Weigao Group Medical Polymer Company Limited - Strengths ................................................................................... 13
Strength - Consistent Top-Line Growth ..................................................................................................................................... 13
Strength - Robust Sales and Marketing Presence .................................................................................................................... 13
Strength - Strong Product Portfolio ........................................................................................................................................... 13
Shandong Weigao Group Medical Polymer Company Limited - Weaknesses.............................................................................. 14
Weakness - Geographical Concentration in China .................................................................................................................... 14
Shandong Weigao Group Medical Polymer Company Limited - Opportunities ............................................................................. 14
Opportunity - Strategic Business Initiatives ............................................................................................................................... 14
Opportunity - Market Growth in Emerging Countries ................................................................................................................. 14
Opportunity - Demographic Trends ........................................................................................................................................... 14
Shandong Weigao Group Medical Polymer Company Limited - Threats ...................................................................................... 15
Threat - Stringent Government Regulations .............................................................................................................................. 15
Threat - Competitive Landscape ............................................................................................................................................... 15
Threat - Industry consolidation .................................................................................................................................................. 15
Shandong Weigao Group Medical Polymer Company Limited - Key Competitors ........................................................................... 16
Section 3 – Company Financial Ratios ............................................................................................................................................. 17
Financial Ratios - Capital Market Ratios........................................................................................................................................... 17
Financial Ratios - Annual Ratios ...................................................................................................................................................... 17
Performance Chart ........................................................................................................................................................................... 19
Financial Performance...................................................................................................................................................................... 19
Financial Ratios - Interim Ratios....................................................................................................................................................... 20
Financial Ratios - Ratio Charts ......................................................................................................................................................... 21
Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 22
Shandong Weigao Group Medical Polymer Company Limited, Medical Equipment, Deals By Year, 2006 to YTD 2012 ............. 22
Shandong Weigao Group Medical Polymer Company Limited, Medical Equipment, Deals By Type, 2006 to YTD 2012 ............. 23
Shandong Weigao Group M